Chagas disease (CD) is an uncommon disease in Europe. Its epidemiology has changed because of mass migration from Latin America to Europe. Herein we describe a congenital case of CD in a Bolivian newborn in Bergamo, the main city of residence for the Bolivian community in Italy. At delivery, serological analyses evidenced IgG antibodies against Trypanosoma cruzi both in the child and mother, as expected. Hemoscopic analyses on peripheral blood were repeatedly negative during the first months of life. Eventually, thanks to T. cruzi Real Time polymerase chain reaction (RT-PCR) positivity on peripheral blood and development of progressive anemia in the following weeks, congenital Chagas disease was diagnosed and benznidazole-based therapy started. A progressive antibodies’ index decrease was observed till negativity (306 days apart). RT-PCR was negative at the end of treatment. Our case is instructive and management of congenital CD is discussed from the perspective of a non-endemic country.
Bargiggia, G., Ruggeri, M., Ortalli, G., Gabrielli, S., Rodari, P., D'Antiga, L., et al. (2018). Congenital Chagas disease in a Bolivian newborn in Bergamo (Italy). LE INFEZIONI IN MEDICINA, 26(1), 93-96.
Congenital Chagas disease in a Bolivian newborn in Bergamo (Italy)
D'Antiga, L;
2018
Abstract
Chagas disease (CD) is an uncommon disease in Europe. Its epidemiology has changed because of mass migration from Latin America to Europe. Herein we describe a congenital case of CD in a Bolivian newborn in Bergamo, the main city of residence for the Bolivian community in Italy. At delivery, serological analyses evidenced IgG antibodies against Trypanosoma cruzi both in the child and mother, as expected. Hemoscopic analyses on peripheral blood were repeatedly negative during the first months of life. Eventually, thanks to T. cruzi Real Time polymerase chain reaction (RT-PCR) positivity on peripheral blood and development of progressive anemia in the following weeks, congenital Chagas disease was diagnosed and benznidazole-based therapy started. A progressive antibodies’ index decrease was observed till negativity (306 days apart). RT-PCR was negative at the end of treatment. Our case is instructive and management of congenital CD is discussed from the perspective of a non-endemic country.File | Dimensione | Formato | |
---|---|---|---|
Bargiggia-2018-InfezMed-VoR.pdf
accesso aperto
Descrizione: InfezMed allows authors the use of the final published version for archiving in an institutional repository after an embargo period of 12 months after publication.
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Altro
Dimensione
641.44 kB
Formato
Adobe PDF
|
641.44 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.